Inventor · disambiguated record
Anis Khusro Mir
Also filed as: MIR ANIS K · MIR ANIS KHUSRO
4 granted patents·8 pending applications·5 citations·filing 2002–2013
65Inventor score
Top patents by PatentIndex Score
12 records- 0164US8535666B2Antibody (11C7) anti Nogo-A and its pharmaceutical useBARSKE CARMEN·Filed 2010·Granted Sep 17, 2013·1 cites·2 claims
- 0263US7785593B2Antibody (11C7) anti nogo a and its pharmaceutical useNOVARTIS AG·Filed 2003·Granted Aug 31, 2010·4 cites·3 claims
- 0355US2010093672A1Use of s1p receptor modulatorBARDE YVES-ALAIN·Filed 2008·Application pending·0 cites
- 0454US9265754B2Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndromeBARDE YVES-ALAIN·Filed 2013·Granted Feb 23, 2016·0 cites·3 claims
- 0552US8163285B2Nogo-A binding molecules and pharmaceutical use thereofBARSKE CARMEN·Filed 2008·Granted Apr 24, 2012·0 cites·12 claims
- 0650US2014011884A1Use of s1p receptor modulatorBARDE YVES-ALAIN·Filed 2013·Application pending·0 cites
- 0747US2012245129A1Use of s1p receptor modulatorBARDE YVES-ALAIN·Filed 2011·Application pending·0 cites
- 0845US2008118951A1Nogo receptor homologues and their useBARSKE CARMEN·Filed 2007·Application pending·0 cites
- 0943US2009181023A1Nogo-a binding with enhanced affinity and pharmaceutical use thereofBARSKE CARMEN·Filed 2004·Application pending·0 cites
- 1043US2004259092A1Nogo receptor homologues and their useFiled 2002·Application pending·0 cites
- 1139US2008317741A1Biomarkers For Anti-Nogo-A Antibody Treatment in Spinal Cord InjuryKINNUNEN ANU·Filed 2006·Application pending·0 cites
- 1236US2011008334A1Nogo-a binding with enhanced affinity and pharmaceutical use thereofNOVARTIS PHARMA AG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anis Khusro Mir files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →